Alex Pu

Alex Pu

Auto-generated profile, based on publicly available information

Alex Pu

University of Maryland Baltimore School of Medicine Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Orthopaedics
Verified
Journal Article
Closed access
APAlex Pu
Alex Pu
Julio J. J. JaureguiJulio J. J. Jauregui
Julio J. J. Jauregui
HSHarold I. Salmons
Harold I. Salmons
TWTristan Buchanan Weir
Tristan Buchanan Weir
JAJoshua Matthew Abzug
Joshua Matthew Abzug
MGMohit N. Gilotra
Mohit N. Gilotra

25 April 2024 in Liver International
Verified
Journal Article
Closed access
DLDavid Uihwan Lee
David Uihwan Lee
AYAshley Yoo
Ashley Yoo
SKSindhura Kolachana
Sindhura Kolachana
JLJaehyun Lee
Jaehyun Lee
RPReid Ponder
Reid Ponder
NUNathalie Helen Urrunaga
Nathalie Helen Urrunaga

14 March 2022 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
ASAmil Sahai
Amil Sahai
DJDerek L. Jones
Derek L. Jones
MHMarcus Hughes
Marcus Hughes
APAlex Pu
Alex Pu
KWKatrina L Williams
Katrina L Williams
MGMohit N. Gilotra
Mohit N. Gilotra
Fibroadipogenic progenitor (FAP) cells are implicated as a major source of fatty infiltration (FI) in murine rotator cuff (RC) injury, but FAP cell response after RC tear in a rabbit model is unknown. This study determined whether changes in FAP cell count after an RC tear predate muscle degeneration in a clinically relevant rabbit model. We hypothesized increases in FAP cell count correlate temporally with RC degeneration. New Zealand white rabbits (n = 26) were evaluated at 1, 2, 4, and 6 weeks after unilateral full‐thickness tenotomy of supraspinatus and infraspinatus tendons. FI area and adipocyte size were histologically analyzed, muscle density was measured by computerized tomography, and quantification of FAP cells was measured by flow cytometry and immunohistochemistry. The percentage of intrafascicular adipocyte area increased over time in supraspinatus muscle samples (p = 0.03), significantly between 1‐ and 6‐week samples (p = 0.04). There were no differences in perifascicular adipocyte area percentages between time points. Peak increase in FAP cell count occurred at 1‐week (p = 0.03), with a decrease in the following weeks. There was a negative correlation between supraspinatus adipocyte area and FAP cell count (p < 0.05). On computed tomography (CT) scan, maximal decrease in muscle density was observed in the 4th to 6th weeks. In summary, FAP cell response occurred early after tenotomy and did not correlate temporally with increases in FI. This suggests that FAP cell response may predate degenerative changes, and early targeting of FAPs before adipocyte maturation could blunt FI after RC tear.

1 October 2021 in World Neurosurgery
Verified
Journal Article
Closed access
DLDavid Love
David Love
JBJacob Bruckner
Jacob Bruckner
IYIvan Ye
Ivan Ye
ATAlexandra Thomson
Alexandra Thomson
APAlex Pu
Alex Pu
JJJulio Jauregui
Julio Jauregui

7 September 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
APAlex Pu
Alex Pu
RARahul V. Annabathula
Rahul V. Annabathula
HAHaytham Allaham
Haytham Allaham
DCDiljon Chahal
Diljon Chahal
STShahab Toursavadkohi
Shahab Toursavadkohi
AGAnuj Gupta
Anuj Gupta
Introduction: Patients with aortic aneurysms are at elevated risk of rupture, dissection and death during and after transcatheter aortic valve repair (TAVR), often requiring consideration for endovascular aneurysm repair (EVAR) at the time of TAVR. However, data comparing outcomes of simultaneous versus staged TAVR‐EVAR are limited. Methods: Using the National Inpatient Sample between the years 2018 and 2021, we compared in‐hospital outcomes of simultaneous and staged TAVR‐EVAR. Patients who underwent both TAVR and EVAR during hospital admission were identified with International Classification of Diseases 10th Revision procedure codes. Patients were stratified by simultaneous (defined as same day) versus staged (defined as different day) procedures. Propensity score matching was done in a 2:1 fashion to account for differences in baseline characteristics, and mixed effects multivariate regression models were used to assess differences in in‐hospital mortality, cost of hospitalization, length of stay, and other procedural complications. Results: A total of 270 patients underwent simultaneous TAVR‐EVAR, while a total of 70 underwent staged TAVR‐EVAR. After propensity score matching, 98 patients undergoing simultaneous TAVR‐EVAR were matched to 49 patients undergoing staged TAVR‐EVAR. No significant differences in baseline characteristics were observed after matching. In‐hospital mortality between the matched groups was not significantly different (OR 0.67, p = 0.409), however the simultaneous group was associated with shorter length of stay (3 [2.0−11.75] days vs. 14 [13.0−17.0] days, p < 0.001) and less total hospital costs ($77,691 [$65,153−$103,854] vs. $148,617 [$128,339−$217,988]; p < 0.001). The matched simultaneous group was also associated with lower incidence of acute kidney injury (25.5% vs. 65.3%; OR 0.11, p < 0.001), blood transfusions (20.4% vs. 40.8%; OR 0.37, p = 0.01), and access site complications (< 10.2% vs. 49.0%; OR 0.00, p < 0.001). Conclusion: Simultaneous TAVR‐EVAR is associated with fewer adverse complications and lower cost of hospitalization without increased in‐hospital mortality, suggesting it is more cost effective than staged TAVR‐EVAR during the same hospital admission.

1 January 2025 in Texas Heart Institute Journal
Verified
Journal Article
Open access
APAlex Pu
Alex Pu
RARahul V. Annabathula
Rahul V. Annabathula
MAManjula G. Ananthram
Manjula G. Ananthram